The market reentry of Reconcile® (fluoxetine hydrochloride) from PRN Pharmacal™ prompted research by AHD staff about separation anxiety. Most recently, Fear Free Happy Homes offered context in the article, “Shadow effect: is it closeness or anxiety?” Link. The writer states, “Separation anxiety rarely gets better on its own and, in fact, often escalates.”
John Ciribassi, DVM, DACVB, addressed veterinarians’ challenges in trying to meet pet and client needs in the face of separation anxiety. The article provides critical insight about owner involvement in the behavior modification component and includes contributions from Karen Felstad, DVM, Shawn Finch, DVM, and Andy Rollo, DVM,
Source: Veterinary Medicine, May 10, 2016. Link.
COMMUNICATE with your clients, advises Ciribassi. Behavior is about management, not cure. It also shows you care about the progress your patient is making. Positioned as a Hail Mary, Rollo offers this perspective, “Just writing a script for an antidepressant and hoping for the best is not the best policy, but it is worth a shot compared to the pet ending up in the pound.”
INSIGHTS: Tested, labeled and approved for use in dogs, Reconcile® along with its BOND™ Training Program offers fresh hope for dogs with separation anxiety and their owners.